市場調査レポート

商品コード

欧州の急性膵炎：2030年までの市場予測 - 地域別分析 - 製品、病因、エンドユーザー別

Europe Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

出版日: 2023年12月26日 | 発行: The Insight Partners

| ページ情報: 英文 113 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 3,550 557,847円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 4,550 714,987円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 5,550 872,127円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

欧州の急性膵炎市場は、2022年に14億9,210万米ドルと評価され、2030年には22億6,069万米ドルに達すると予測され、2022年から2030年までのCAGRは5.3%で成長すると予測されています。

急性膵炎後の糖尿病罹患率の上昇が欧州の急性膵炎市場を後押し

膵臓は、血糖値を調節するホルモンであるインスリンを産生します。膵炎は膵臓のインスリン産生細胞を傷つけ、急性膵炎を患う患者に糖尿病を引き起こします。急性膵炎に罹患した人は、一般の人に比べて糖尿病のリスクが2倍高くなります。糖尿病の後遺症は急性膵炎の重症度範囲にわたって観察され、他の臨床合併症を伴うこともあります。

2022年に発表されたEuropean Review for Medical and Pharmacological Sciencesによると、欧米の糖尿病患者集団における膵原性糖尿病の有病率は5～10％で、慢性膵炎が20％を占める一方、急性膵炎が80％を占めています。2021年にNational Library of Medicineに掲載された論文によると、急性膵炎患者の～23％が退院後3年以内に糖尿病を発症する可能性が高いです。さらに、2020年にJournal of Gastroenterology誌に発表された論文によると、急性膵炎後、退院後6ヶ月、12ヶ月、18ヶ月、24ヶ月の時点で、それぞれ～3%、7%、9%、11%の患者が糖尿病を発症します。MDPIに掲載された論文によると、2023年には急性膵炎患者の～40％が糖尿病予備軍や糖尿病に罹患しており、2型糖尿病患者よりも死亡や再入院のリスクが高いです。さらに、成人患者の～60.2％が急性膵炎後に糖尿病を発症し、小児の9％が急性再発性膵炎後または慢性膵炎後に糖尿病を発症し、このリスクは成人期になるにつれて増加します。調査者は、重症と軽症の急性膵炎を比較したメタアナリシスにおいて、重症急性膵炎後の糖尿病発症率（～39％）が軽症急性膵炎後（14％）よりも高いことを指摘しています。このように、急性膵炎に罹患または回復した患者における糖尿病発症率の増加は、欧州の急性膵炎市場の成長に寄与しています。

欧州の急性膵炎市場の概要

欧州の急性膵炎市場は、ドイツ、英国、フランス、イタリア、スペイン、北欧諸国、オランダ、その他欧州に区分されます。ドイツや英国などの国々は、この地域の市場に対する最大の貢献者になると予想されます。急性膵炎の有病率の上昇とアルコール消費の増加は、欧州の市場成長を促進する主な要因です。連邦統計局によると、ドイツの医療費は2019年に4,600億3,000万米ドルに達しました。ヘルスケアに対する革新的なアプローチにより、急性膵炎の治療製品を提供する企業にとって魅力的な市場です。ドイツの医療機器メーカーは、さまざまな研究プロジェクトに対して政府からの資金援助を求めたり、Kreditanstalt fur Wiederaufbau（KfW）から助成金を受けたりすることもできます。急性膵炎のような高度な診断機器を開発するために、新製品開発や戦略的提携に注力するメーカーが増加していることは、今後数年間の市場成長をさらに促進すると予想されます。

欧州の急性膵炎市場の収益と2030年までの予測（US$Mn）

欧州の急性膵炎市場のセグメンテーション

欧州の急性膵炎市場は、提供、病因、エンドユーザー、国別に細分化されます。

提供に基づき、欧州の急性膵炎市場は投薬、診断、その他にセグメント化されます。診断セグメントは2022年に最大の市場シェアを占めました。

方法に基づき、欧州の急性膵炎市場は胆石、アルコール中毒、遺伝性疾患、感染症、その他に区分されます。胆石セグメントは2022年に最大の市場シェアを占めました。

エンドユーザー別では、欧州の急性膵炎市場は病院、診断研究所、外来手術センター、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、欧州の急性膵炎市場は、英国、ドイツ、フランス、イタリア、スペイン、北欧諸国、オランダ、その他欧州に区分されます。2022年の欧州の急性膵炎市場シェアはドイツが独占。

Abbott Laboratories社、Actim Oy社、Baxter International Inc社、Boston Scientific Corp社、Dynavax Technologies Corp社、Fresenius Kabi AG社、GE HealthCare Technologies Inc社、Koninklijke Philips NV社、Medtronic Plc社、Samsung Healthcare社は、欧州の急性膵炎市場で事業を展開している大手企業の一部です。

主要市場促進要因
- 急性膵炎による膵がん患者の増加
- 急性膵炎後の糖尿病罹患率の上昇
主な市場抑制要因
- 膵炎および膵がん治療の副作用
主な市場機会
- 急性膵炎に関する研究開発活動および啓発プログラムの増加
今後の動向
- 特定の急性膵炎治療の進歩
インパクト分析

第6章急性膵炎市場-欧州市場分析

欧州の急性膵炎市場売上高、2022年～2030年

第7章欧州の急性膵炎市場：収益と2030年までの予測：提供別

市場収益シェア、2022年・2030年（%）
薬剤
診断
その他

第8章欧州の急性膵炎市場：収益と2030年までの予測：病因別

市場収益シェア、2022年・2030年（%）
胆石症
アルコール中毒
遺伝性疾患
感染症
その他

第9章欧州の急性膵炎市場：収益と2030年までの予測：エンドユーザー別

市場収益シェア、2022年・2030年（%）
病院
診断研究所
外来手術センター
その他

第10章欧州の急性膵炎市場：国別分析

欧州の急性膵炎市場：国別
英国
ドイツ
フランス
イタリア
スペイン
北欧地域
オランダ
その他欧州

第11章欧州の急性膵炎市場：業界情勢

欧州の急性膵炎市場における成長戦略
無機的成長戦略
有機的成長戦略

第12章企業プロファイル

Abbott Laboratories
GE HealthCare Technologies Inc
Samsung Healthcare
Koninklijke Philips NV
Baxter International Inc
Dynavax Technologies Corp
Actim Oy
Medtronic Plc
Boston Scientific Corp
Fresenius Kabi AG

第13章付録

図表

List Of Tables

Table 1. Europe Acute Pancreatitis Market Segmentation
Table 2. Europe Acute Pancreatitis Market, by Medications - Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Acute Pancreatitis Market, by Diagnosis - Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 8. UK: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 15. France: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 18. France: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 29. Nordic Region: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 30. Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 31. Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 32. Nordic Region: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 33. Nordic Region: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 34. Netherlands: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 35. Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 36. Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 37. Netherlands: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 38. Netherlands: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Europe: Europe Acute Pancreatitis Market, by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 40. Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings - Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe: Europe Acute Pancreatitis Market, by Causes - Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe: Europe Acute Pancreatitis Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 44. Recent Inorganic Growth Strategies in the Europe Acute Pancreatitis Market
Table 45. Recent Organic Growth Strategies in the Europe Acute Pancreatitis Market
Table 46. Glossary of Terms, Europe Acute Pancreatitis Market

List Of Figures

Figure 1. Europe Acute Pancreatitis Market Segmentation, By Country
Figure 2. Europe Acute Pancreatitis Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acute Pancreatitis Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 21. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in the Europe Acute Pancreatitis Market

Product Code: BMIRE00029223

The Europe acute pancreatitis market was valued at US$ 1,492.10 million in 2022 and is expected to reach US$ 2,260.69 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Rising Incidence of Diabetes Following Acute Pancreatitis Fuels the Europe Acute Pancreatitis Market

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5-10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the Europe acute pancreatitis market.

Europe Acute Pancreatitis Market Overview

The Europe acute pancreatitis market is segmented into Germany, the UK, France, Italy, Spain, Nordic Countries, The Netherlands, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of acute pancreatitis and increase in alcohol consumption are the major factors driving the market growth in Europe. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 460.03 billion in 2019. It is an attractive market for companies offering therapeutic products for acute pancreatitis due to its innovative approach toward healthcare. Medical device manufacturers in Germany can also seek government funding for a variety of research projects and receive grants from the Kreditanstalt fur Wiederaufbau (KfW). The increasing focus of manufacturers on new product development and strategic collaborations to develop advanced diagnostic devices such as acute pancreatitis is expected to further propel the market growth in the coming years.

Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Europe Acute Pancreatitis Market Segmentation

The Europe acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Europe acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Europe acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Europe acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe acute pancreatitis market is segmented into the U.K., Germany, France, Italy, Spain, the Nordic Countries, the Netherlands, and the Rest of Europe. Germany dominated the Europe acute pancreatitis market share in 2022.

Abbott Laboratories, Actim Oy, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Europe acute pancreatitis market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Europe Acute Pancreatitis Market, by Country (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Acute Pancreatitis Market Landscape

4.1 Overview

5. Europe Acute Pancreatitis Market - Key Industry Dynamics

5.1 Key Market Drivers
- 5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
- 5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
- 5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
- 5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
- 5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:

6. Acute Pancreatitis Market - Europe Market Analysis

6.1 Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 - 2030

7. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

7.1 Overview
7.2 Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
- 7.3.1 Overview
- 7.3.2 Medications: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.3.2.1 Europe Acute Pancreatitis Market, by Medications, 2020-2030 (US$ Million)
7.4 Diagnosis
- 7.4.1 Overview
- 7.4.2 Diagnosis: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 Europe Acute Pancreatitis Market, by Diagnosis, 2020-2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

8.1 Overview
8.2 Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
- 8.3.1 Overview
- 8.3.2 Gallstones: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
- 8.4.1 Overview
- 8.4.2 Alcoholism: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
- 8.5.1 Overview
- 8.5.2 Genetic Disorders: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
- 8.6.1 Overview
- 8.6.2 Infections: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
- 9.4.1 Overview
- 9.4.2 Diagnostic Laboratories: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
- 9.5.1 Overview
- 9.5.2 Ambulatory Surgical Centers: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acute Pancreatitis Market - Country Analysis

10.1 Overview

11. Europe Acute Pancreatitis Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Europe Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Abbott Laboratories
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Samsung Healthcare
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Koninklijke Philips NV
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Dynavax Technologies Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Actim Oy
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medtronic Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boston Scientific Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Fresenius Kabi AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

欧州の急性膵炎：2030年までの市場予測 - 地域別分析 - 製品、病因、エンドユーザー別

Europe Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州の急性膵炎市場情勢

第5章欧州の急性膵炎市場-主要産業力学

第6章急性膵炎市場-欧州市場分析

第7章欧州の急性膵炎市場：収益と2030年までの予測：提供別

第8章欧州の急性膵炎市場：収益と2030年までの予測：病因別

第9章欧州の急性膵炎市場：収益と2030年までの予測：エンドユーザー別

第10章欧州の急性膵炎市場：国別分析

第11章欧州の急性膵炎市場：業界情勢

第12章企業プロファイル

第13章付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Acute Pancreatitis Market Landscape

5. Europe Acute Pancreatitis Market - Key Industry Dynamics

6. Acute Pancreatitis Market - Europe Market Analysis

7. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

8. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

9. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

10. Europe Acute Pancreatitis Market - Country Analysis

11. Europe Acute Pancreatitis Market-Industry Landscape

12. Company Profiles

13. Appendix

欧州の急性膵炎：2030年までの市場予測 - 地域別分析 - 製品、病因、エンドユーザー別

Europe Acute Pancreatitis Market Forecast to 2030 - Regional Analysis - by Offerings, Causes, and End User

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 欧州の急性膵炎市場情勢

第5章 欧州の急性膵炎市場-主要産業力学

第6章 急性膵炎市場-欧州市場分析

第7章 欧州の急性膵炎市場：収益と2030年までの予測：提供別

第8章 欧州の急性膵炎市場：収益と2030年までの予測：病因別

第9章 欧州の急性膵炎市場：収益と2030年までの予測：エンドユーザー別

第10章 欧州の急性膵炎市場：国別分析

第11章 欧州の急性膵炎市場：業界情勢

第12章 企業プロファイル

第13章 付録

List Of Tables

List Of Figures

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Europe Acute Pancreatitis Market Landscape

5. Europe Acute Pancreatitis Market - Key Industry Dynamics

6. Acute Pancreatitis Market - Europe Market Analysis

7. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Offerings

8. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by Causes

9. Europe Acute Pancreatitis Market - Revenue and Forecast to 2030 - by End User

10. Europe Acute Pancreatitis Market - Country Analysis

11. Europe Acute Pancreatitis Market-Industry Landscape

12. Company Profiles

13. Appendix

第1章イントロダクション

第2章エグゼクティブサマリー

第3章調査手法

第4章欧州の急性膵炎市場情勢

第5章欧州の急性膵炎市場-主要産業力学

第6章急性膵炎市場-欧州市場分析

第7章欧州の急性膵炎市場：収益と2030年までの予測：提供別

第8章欧州の急性膵炎市場：収益と2030年までの予測：病因別

第9章欧州の急性膵炎市場：収益と2030年までの予測：エンドユーザー別

第10章欧州の急性膵炎市場：国別分析

第11章欧州の急性膵炎市場：業界情勢

第12章企業プロファイル

第13章付録